Pharma

Views & Analysis

Independent health comms agencies rebrand with emphasis on a...

In a world of a million messages, should authenticity be the common thread tying all pharma communications and marketing activities together?

Views & Analysis

Why the drug pricing debate is focused on insulin

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products.

News

CMO John Tsai exits, as Novartis starts revamp that aims to ...

Novartis chief executive Vas Narasimhan, already eyeing a possible divestment of generics business Sandoz, has now turned his attention to the rest of the company.

Sales & Marketing

Coaching Consistency

Leading tennis players train two to three hours a day to prepare for tournaments and have daily coaching input to make them game ready.

News

New blow for ALS pipeline as Biogen and Ionis candidate fail...

Less than six months after the late-stage failure of tofersen, Biogen and Ionis have suffered further disappointment in the amyotrophic lateral sclerosis (ALS) pipeline after BIIB078 (IONIS-C9Rx) f

Podcasts

Big data and how it can change the game in pharma: the pharm...

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet-- before joining COTA last